GlassScriptPhysician profile
Deana T Nes
NPI 1851710040
$7,226.52
in general payments reported to CMS, 2019-2025
48 companies · $2,071 in 2025
The $2,071 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $266 · 2021: $12.86 · 2022: $957 · 2023: $1,656 · 2024: $1,855 · 2025: $2,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,507 · Education: $75.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,506.92 |
| Education | $75.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $937.05 | 2019-2025 | Evenity, Enbrel, Tavneos |
| Abbvie INC. | $847.43 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $749.72 | 2019-2025 | |
| Ucb, INC. | $619.34 | 2019-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $574.64 | 2019-2025 | Tremfya, Simponi Aria |
| Ani Pharmaceuticals, INC. | $407.11 | 2022-2025 | Purified Cortrophin Gel, Sovuna |
| Lilly USA, LLC | $307.29 | 2019-2025 | Taltz, Omvoh |
| Pfizer INC. | $306.60 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $221.47 | 2022-2025 | Acthar |
| Fidia Pharma USA INC. | $219.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $198.59 | 2019-2025 | Orencia |
| Alexion Pharmaceuticals, INC. | $181.11 | 2022-2025 | Strensiq |
| Corcept Therapeutics | $143.09 | 2024 | Korlym |
| Ascendis Pharma Endocrinology INC | $124.98 | 2023 | |
| Radius Health, INC. | $118.08 | 2019-2025 | Tymlos |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deana Nes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.